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radicating polio - Building the boat while sailing
. John
Christian Medical College, Vellore, India
In 2012 we are at a peculiar juncture of polio eradication.
here are sufﬁcient reasons for optimism, but there are also many
nknowns ahead. Wild poliovirus (WPV) type 2 was eradicated
n 1999, providing proof of principle that WPV 1 and 3 can also
e eradicated. Only in parts of 3 countries, Nigeria, Pakistan and
fghanistan, WPV 1 and 3 transmissions have not yet been inter-
upted.
The exclusive use of trivalent OPV (tOPV) had some justiﬁ-
ations but also major problems not exactly unpredicted. OPV
as wide geographic variations of efﬁcacy and inherent geno-
ypic/phenotypic tendency to de-attenuate. Where WPV 1 and 3
ransmissions were intense in infancy, the efﬁcacy of types 1 and 3
n tOPVwas particularly low. Since 2005monovalent OPVs (mOPV-
and3)with superior efﬁcacy are in use, overcoming the inhibitory
ffect of type 2 vaccine virus. In 2009, a bivalent OPV (bOPV) con-
aining type 1 and 3 was tested and found non-inferior to mOPVs.
ince then bOPV is widely used. Many doubt if WPV 1 or 3 could
ave been eradicated with tOPV.
For 12 years type 2 vaccine virus was fed to children although
PV 2 was eradicated. Since vaccine viruses cause polio as an
dverse reaction (vaccine-associated paralytic polio, VAPP), an eth-
cal dilemma emerged: type 2 VAPP while there is no type 2 WPV
olio. Moreover, de-attenuated vaccine viruses with genotypic and
henotypic properties of neuro-virulence and easy transmissibil-
ty – called ‘vaccine-derived polioviruses’ (VDPVs) have emerged
n many locations where OPV is being used. Post-WPV eradication
PV must be discontinued to stop VAPP, but then silent transmis-
ions of VDPVs will ﬂare up, capturing the niche left by WPVs. True
olio eradicationmust be deﬁned as zero infectionworldwidewith
ild and vaccine viruses.
The availability of bOPV presents the opportunity to use it
nstead of tOPV – thus avoiding seeding of vaccine type 2 virus
ny more in the community. However, VDPV-2 circulation must be
nticipated; to preempt and intercept it immunity umbrella with
nactivated poliovaccine (IPV)must be established before replacing
OPVwith bOPV. Once that tactic is found successful, theworldwill
e ready to stop all OPV after global eradication (and certiﬁcation)
f WPV 1 and 3.
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Vaccination programs in Southeast Asia
U. Thisyakorn
Chulalongkorn University, Bangkok, Thailand
Southeast Asia is one of the most densely populated areas
around the world and suffers from large disease burdens of
commonpediatric infectious diseases includingdiarrhea andpneu-
monia. The national vaccination programs and vaccine uptake
of conventional vaccines in this area showed that children in
most countries were well protected from conventional vaccine-
preventable diseases. Differences in vaccine antigens that were
used and variations in time schedules for certain vaccines existed.
Protection against newly developed vaccines such as rotavirus,
pneumococcus and human papillomavirus infections were obvi-
ously inadequate in most of the countries in this area. Children in
Southeast Asia are still suffering from certain vaccine-preventable
diseases. Promoting coverage of newly developed vaccines will
beneﬁt a great number of children in this area. Strengthening of
vaccination for special groups such as adults, health care work-
ers, immunocompromised hosts, pregnant women and travelers is
urgently needed.
Vaccines are unquestionably one of the most cost-effective
public health measures available, yet they are undervalued and
under-utilised throughout the world. It is important for interna-
tional agencies, governments, and health policy makers to keep
this preventive measure in the spotlight. Ultimately, it is the global
society and future generations that beneﬁtwhenall countriesmake
the effort to protect their population fromvaccine-preventable dis-
eases.
http://dx.doi.org/10.1016/j.ijid.2012.05.140
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Facing anti-vaccine movements: Myths and facts about adverse
events
K. Powell
Children’s Hospital Medical Center of Akron Department of Pediatrics,
Akron, OH, USA
Anti-vaccine movements are motivated variously by political,
cultural, and/or personal factors. Three tactics used by anti-vaccine
activists are 1) creating doubt about vaccine safety, 2) insistence on
the individual’s right to decide about vaccination, and 3) requiring
that research be done to address the activists’ concerns. Examples
of anti-vaccine activities illustrate these points.
A paper by Wakeﬁeld, published in the UK in1998 and subse-
quently retracted, claimed that autism was caused by the MMR
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accine. Information in thispaperwasusedbyanti-vaccineactivists
o argue against the use of MMR and led to decreased coverage and
esultant measles outbreaks.
A policy change in 1999 recommended by the American
cademy of Pediatrics and the US Centers for Disease Control to
emove thimerosal from vaccines fueled the rumor that thimerosal
aused autism. This rumor resulted in thousands of claims of vac-
ine injury and a decrease in the rate of neonatal hepatitis B
mmunization.
In 2003 religious and political leaders in Nigeria encouraged
oycotts of oral polio vaccine, claiming that it was contaminated
ith HIV and could cause sterilization in vaccinees. This politi-
ally motivated assertion resulted in a polio outbreak in Nigeria
nd subsequent polio outbreaks in 15 other countries.
A 1994 report on a birth control vaccine using tetanus toxoid as
carrier sparked a rumor that tetanus toxoid could cause sterility.
his misinformation, spread by Catholic organizations through 60
ountries in South and Central America, resulted in a 45% drop in
accination coverage.
The intuitive approach to combating vaccinemyths is to provide
actual information to refute the myth. The method by which the
actual information is presented is important. Research onmemory
erformance demonstrated that repetition of a myth in order to
efute it frequently led to the false information being remembered
s true.
To effectively face anti-vaccine movements the full range of
olitical, cultural, and psychological factors affecting individual
ecision making must be considered and used in building public
rust. In view of the way human memory works, presentation and
epetition of facts should replace reiteration of the false myths.
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he pre-transplant evaluation
. Smitasin
Vejthani Hospital, Bangkok, Thailand
The science of transplantation has advanced tremendously
ince the discovery of immunosuppressive agents. With the potent
mmunosuppressive agents but less adverse effects, patient can live
onger and has better quality of life. In order to achieve this goal,
re-transplant evaluation is crucial in decreasing and eliminating
nfectious complications after immunosuppression.
The objectives of pre-transplant evaluation are to identify and
reat active infection, deﬁne the risk of infection and implement
he strategies to prevent infection post-transplant period.
Detail history taking is the key to successfully managing and
reventing infectious complication pre- and post-transplantation.
erological and immunological tests for infections, such as her-
es virus, syphilis, HIV and Mycobacterium tuberculosis, identify
atients with latent infections which lead to pre-transplant vac-
ination, treatment and appropriate post-transplant antimicrobial
rophylaxis. Patient with active infection should be treated in
imely fashion prior to intense immunosuppression to avoid exac-
rbation of the disease. History of travel, occupation and daily
ctivity suggests speciﬁc tests of infections in each geographicalnfectious Diseases 16S (2012) e2–e157
area. Life-style modiﬁcation is recommended in order to decrease
exposure to infection pre- and post-transplantation.
http://dx.doi.org/10.1016/j.ijid.2012.05.142
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Donor derived infections
G. Reid
University of Illinois, Chicago, IL, USA
Infections are a signiﬁcant complication of solid organ trans-
plantations (SOT). Although many of these infections are due to
surgical complications and pre- and posttransplant exposure of
immunocompromised individuals to pathogens in the hospital
and in their daily activities at home, another potential source of
infection in these individuals derives from their donors. Usually
cadaveric donors are not known and family members giving con-
sent may not know all of their history. In such cases the life saving
organs can potentially pose a threat to the lives of the recipients
they were meant to save.
Several methods can decrease risk of this occurring: screen-
ing of donor medical, social, and travel history, and screening of
donor blood for not only common infectious contraindications,
such as HIV and viral hepatitis, but also infections endemic to
their travel history. Additionally, having tightly regulated policies,
autopsy conﬁrmation of cause of death and comorbidities of donor,
and ease of communication between transplant centers can con-
tribute to decreasing morbidity and mortality from donor derived
infections.
Having a framework in place to address the risk of donor derived
infections at numerous levels is key to decreasing the likelihood
of this potentially catastrophic event, which can affect numerous
recipients’ lives.
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State of the art: Transplantation in HIV infected individuals
M. Brito
University of Illinois at Chicago, Chicago, IL, USA
The introduction of Highly Active Antiretroviral Therapy in the
mid-1990’s has had a signiﬁcant impact in the morbidity and
mortality of patients infected with the Human Immunodeﬁciency
Virus (HIV). Diseases previously deemed untreatable in this patient
population are now the focus of intense research. Cirrhosis and
decompensated liver disease, secondary to a more rapid progres-
sion of Hepatitis C virus infection, and end-stage renal disease,
cause signiﬁcant morbidity in otherwise healthy and virologically
